Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
A: Yes, but cold-chain management is critical
Te recomendamos verificar las especificaciones con el fabricante para obtener detalles ms actualizados
For the BPC-157 vs TB-500 comparison, see BPC-157 vs TB-500
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
Cureus 16:e71392
Clinical trials have used doses up to 8,000 mg/day for extended periods
US$ 25.65
US$ 26.48
US$ 29.35
